Pheno Therapeutics

Developer of remyelinating therapies for multiple sclerosis

placeEdinburgh, Scotland, United Kingdom calendar_todayFounded 2019 groups2 employees language phenotherapeutics.com

Registered entities

Social engagement

Social engagement: 899 social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Scottish Investment Bank, Advent Life Sciences, LifeArc, Brandon Capital.

Investor typeCountShare
Venture capital563%
Other / undisclosed338%

Recent activity

22 Jun 2026
Milestone
regulatory
22 Dec 2025
Event
Biotech Showcase
Coming soon